Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma

Clinic outcome of gefitinib in sixty-nine elderly patients with lung adenocarcinoma

Background and Objective To evaluate the efficacy and safety of gefitinib, an orally active epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI), in elderly patients with other types of adenocarcinoma. Methods The clinical characteristics, response of treatment and survival were retr...

Full description

Bibliographic Details
Main Authors: Datong CHU, Yan SUN, Ziping WANG, Bin WANG, Yan WANG, Xiangru ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2008-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Non-small-cell lung cancer
Elderly
Gefitinib
Adenocarcinoma
Online Access:http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.01.029&path%5B%5D=35

Internet

http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.01.029&path%5B%5D=35

Similar Items